Briefs: Panacea Biotec, Lotus Eye Hospital and Uflex
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio
Through the new DTP platform, Novartis will make Cosentyx available to patients at a price that reflects the average savings typically retained by insurers and pharmacy benefit managers
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
The product will be manufactured at Lupin’s Chhatrapati Sambhajinagar facility in India
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
The expansion will significantly enhance AbbVie’s ability to meet growing global demand for biologics, particularly in oncology and immunology
Subscribe To Our Newsletter & Stay Updated